AKP-11 is under clinical development by Akaal Pharma and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I drugs for Autoimmune Disorders have a 73% phase transition ...

A comprehensive guide to making the most of your remaining healthcare funds. As December winds down, millions of Americans ...

Diddy has been locked up at the notoriously tough Metropolitan Detention Center in Brooklyn, N.Y., since September ...

Scilex Holding (NASDAQ:SCLX – Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 5,280,000 shares, a ...

Goflikicept is under clinical development by R-Pharm and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

INR:1503. cbtf login A large number of new gout drugs are coming! Hengrui is striving to develop the first domestically produced Class 1 new drug Hengrui Medicine's th ...

INR:5898. jungle gorilla la defense Competition is fierce! Henlius Biopharmaceuticals' Bevacizumab Biosimilar is listed The third batch of centralized p ...

INR:2117. stellar win casino login Understanding the diagnosis and treatment of epilepsy in one article ORR up to 59%! Phase Ib trial data of PD-1 antibo ...